A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

NCT06958536 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: SAR442970
DRUG: Placebo

Sponsor

Sanofi